These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 8453644)

  • 61. Relationship between e-cadherin expression and lymph-node metastasis in human esophageal cancer.
    Miyata M; Shiozaki H; Iihara K; Shimaya K; Oka H; Kadowaki T; Inoue M; Tamura S; Takeichi M; Mori T
    Int J Oncol; 1994 Jan; 4(1):61-5. PubMed ID: 21566890
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Invasive Micropapillary Carcinoma of the Breast: Immunophenotypic Analysis and Role of Cell Adhesion Molecules (CD44 and E-Cadherin) in Nodal Metastasis.
    Badyal RK; Bal A; Das A; Singh G
    Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):151-8. PubMed ID: 26200840
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Receptors for epidermal growth factor and steroid hormones in human breast cancer.
    Battaglia F; Polizzi G; Scambia G; Rossi S; Panici PB; Iacobelli S; Crucitti F; Mancuso S
    Oncology; 1988; 45(6):424-7. PubMed ID: 3186151
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of E-cadherin expression in non-small cell lung cancer.
    Lim SC; Jang IG; Kim YC; Park KO
    J Korean Med Sci; 2000 Oct; 15(5):501-6. PubMed ID: 11068984
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Estrogen receptor content in primary breast carcinomas and their metastases.
    Tani E; Nordenskjöld B; Humla S; Skoog L
    Anticancer Res; 1988; 8(1):169-71. PubMed ID: 3358632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma.
    Jones JL; Royall JE; Walker RA
    Br J Cancer; 1996 Oct; 74(8):1237-41. PubMed ID: 8883410
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Correlation between E-cadherin expression and metastasis in human breast cancer: preliminary report].
    Oka H; Shiozaki H; Kobayashi K; Tahara H; Kobayashi T; Takatsuka Y; Mori T
    Nihon Geka Gakkai Zasshi; 1992 Jan; 93(1):105. PubMed ID: 1549089
    [No Abstract]   [Full Text] [Related]  

  • 68. The mechanism and significance of E-cadherin, anti-apoptosis B-cell lymphoma-2 protein and sE-cadherin roles in cancer.
    Liu L; Li HX; Lv XQ
    J Biol Regul Homeost Agents; 2014; 28(4):683-91. PubMed ID: 25620178
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The expression of cadherin-catenin complex in association with the clinicopathologic features of early gastric cancer.
    Xiangming C; Hokita S; Nuruki K; Toyoyama H; Tanabe G; Baba M; Takao S; Aikou T
    Surg Today; 1998; 28(6):587-94. PubMed ID: 9681606
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heterogeneous breast tumoroids: An in vitro assay for investigating cellular heterogeneity and drug delivery.
    Vamvakidou AP; Mondrinos MJ; Petushi SP; Garcia FU; Lelkes PI; Tozeren A
    J Biomol Screen; 2007 Feb; 12(1):13-20. PubMed ID: 17166827
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas.
    Hunt NC; Douglas-Jones AG; Jasani B; Morgan JM; Pignatelli M
    Virchows Arch; 1997 Apr; 430(4):285-9. PubMed ID: 9134039
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer.
    Moran RE; Black MM; Alpert L; Straus MJ
    Cancer; 1984 Oct; 54(8):1586-90. PubMed ID: 6478400
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer.
    Matsui S; Shiozaki H; Inoue M; Tamura S; Doki Y; Kadowaki T; Iwazawa T; Shimaya K; Nagafuchi A; Tsukita S
    Virchows Arch; 1994; 424(4):375-81. PubMed ID: 8205352
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer.
    Oka H; Shiozaki H; Kobayashi K; Tahara H; Tamura S; Miyata M; Doki Y; Iihara K; Matsuyoshi N; Hirano S
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(2):149-56. PubMed ID: 1514246
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer.
    Hu QP; Kuang JY; Yang QK; Bian XW; Yu SC
    Int J Cancer; 2016 Jun; 138(12):2804-12. PubMed ID: 26704932
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correlation between expression of cell adhesion molecules CD₄₄ v6 and E-cadherin and lymphatic metastasis in non- small cell lung cancer.
    Su CY; Li YS; Han Y; Zhou SJ; Liu ZD
    Asian Pac J Cancer Prev; 2014; 15(5):2221-4. PubMed ID: 24716905
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assay of E-cadherin by ELISA in human breast cancers.
    Maguire TM; Shering SG; McDermott EW; O'Higgins N; Fennelly JJ; Crown J; Duffy MJ
    Eur J Cancer; 1997 Mar; 33(3):404-8. PubMed ID: 9155524
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relationship of DNA ploidy, cell kinetics, estrogen receptor and clinical status in patients with breast cancer.
    Kuo SH; Lin CC; Yu SC; Liaw KY; Wei TC; Chen KM
    Taiwan Yi Xue Hui Za Zhi; 1985 Nov; 84(11):1260-9. PubMed ID: 3868701
    [No Abstract]   [Full Text] [Related]  

  • 79. Loss of retinal cadherin facilitates mammary tumor progression and metastasis.
    Agiostratidou G; Li M; Suyama K; Badano I; Keren R; Chung S; Anzovino A; Hulit J; Qian B; Bouzahzah B; Eugenin E; Loudig O; Phillips GR; Locker J; Hazan RB
    Cancer Res; 2009 Jun; 69(12):5030-8. PubMed ID: 19491271
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of SATB1 and E-cad in tissues of patients with endometrial carcinoma and the relationship with clinicopathological features.
    Feng Y; Wang X; Wang Q
    Exp Ther Med; 2018 May; 15(5):4339-4343. PubMed ID: 29725375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.